Highly sensitive detection of Dengue virus nucleic acid in samples from clinically ill patients

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 927-931

  Muñoz Jordán, Jorge L ^a,b   Collins, Cynthia S ^b   Vergne, Edgardo ^a   Santiago, Gilberto A ^a   Petersen, Lyle ^c   Sun, Wellington ^a   Linnen, Jeffrey M ^b  

^a Gen Probe Incorporated   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ACUTE PHASE RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; EARLY DIAGNOSIS; GENE AMPLIFICATION; HEMORRHAGIC FEVER; HUMAN; INTERMETHOD COMPARISON; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PUERTO RICO; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TROPICS; VIREMIA; VIRUS DETECTION; BLOOD; COMPARATIVE STUDY; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; NUCLEIC ACID AMPLIFICATION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

DENGUE VIRUS;

BLOOD; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PUERTO RICO; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 65249173896     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01564-08     Document Type: Article

References (37)

1. Brunkard, J. M., J. L. Robles Lopez, J. Ramirez, E. Cifuentes, S. J. Rothenberg, E. A. Hunsperger, C. G. Moore, R. M. Brussolo, N. A. Villarreal, and B. M. Haddad. 2007. Dengue fever seroprevalence and risk factors, TexasMexico border, 2004. Emerg. Infect. Dis. 13:1477-1483.
2. Busch, M. P., S. Caglioti, E. F. Robertson, J. D. McAuley, L. H. Tobler, H. Kamel, J. M. Linnen, V. Shyamala, P. Tomasulo, and S. H. Kleinman. 2005. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N. Engl. J. Med. 353:460-467.
3. Chao, D. Y., B. S. Davis, and G. J. Chang. 2007. Development of multiplex real-time reverse transcriptase PCR assays for detecting eight medically important flaviviruses in mosquitoes. J. Clin. Microbiol. 45:584-589.
4. Chien, L. J., T. L. Liao, P. Y. Shu, J. H. Huang, D. J. Gubler, and G. J. Chang. 2006. Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J. Clin. Microbiol. 44:1295-1304.
5. Cobra, C., J. G. Rigau-Perez, G. Kuno, and V. Vorndam. 1995. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am. J. Epidemiol. 142:1204-1211.
6. Cologna, R., P. M. Armstrong, and R. Rico-Hesse. 2005. Selection for virulent dengue viruses occurs in humans and mosquitoes. J. Virol. 79:853-859.
7. Gratz, N., and A. Knudsen. 1995. The rise and spread of dengue and dengue haemorrhagic fever and its vectors. A historical review (up to 1995). World Health Organization, Geneva, Switzerland.
8. Gubler, D. J., W. Suharyono, R. Tan, M. Abidin, and A. Sie. 1981. Viraemia in patients with naturally acquired dengue infection. Bull. W. H. O. 59:623630.
9. Guzman, M. G., and G. Kouri. 2004. Dengue diagnosis, advances and challenges. Int. J. Infect. Dis. 8:69-80.
10. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
11. Hanna, J. N., S. A. Ritchie, A. R. Richards, C. T. Taylor, A. T. Pyke, B. L. Montgomery, J. P. Piispanen, A. K. Morgan, and J. L. Humphreys. 2006. Multiple outbreaks of dengue serotype 2 in north Queensland, 2003/04. Aust. N. Z. J. Public Health 30:220-225.
12. Holmes, E. C., and S. S. Twiddy. 2003. The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. Evol. 3:19-28.
13. Johnson, B. W., B. J. Russell, and R. S. Lanciotti. 2005. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 43:4977-4983.
14. Kalayanarooj, S., D. W. Vaughn, S. Nimmannitya, S. Green, S. Suntayakorn, N. Kunentrasai, W. Viramitrachai, S. Ratanachu-eke, S. Kiatpolpoj, B. L. Innis, A. L. Rothman, A. Nisalak, and F. A. Ennis. 1997. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 176:313-321.
15. Lanciotti, R. S. 2003. Molecular amplification assays for the detection of flaviviruses. Adv. Virus Res. 61:67-99.
16. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos, C. de
17. C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
18. Linnen, J. M., M. L. Deras, J. Cline, W. Wu, A. S. Broulik, R. E. Cory, J. L. Knight, M. M. Cass, C. S. Collins, and C. Giachetti. 2007. Performance evaluation of the PROCLEIX West Nile virus assay on semi-automated and automated systems. J. Med. Virol. 79:1422-1430.
19. Linnen, J. M., E. Vinelli, E. C. Sabino, L. H. Tobler, C. Hyland, T. H. Lee, D. P. Kolk, A. S. Broulik, C. S. Collins, R. S. Lanciotti, and M. P. Busch. 2008. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 48:1355-1362.
20. Mackenzie, J. S., D. J. Gubler, and L. R. Petersen. 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:S98-S109.
21. Mohammed, H., J. M. Linnen, J. L. Muñoz-Jordán, K. Tomashek, G. A. Foster, A. S. Broulik, L. R. Petersen, and S. L. Stramer. 2008. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 48:1348-1354.
22. Nishiura, H., and S. B. Halstead. 2007. Natural history of dengue virus (DENV) -1 and DENV-4 infections: reanalysis of classic studies. J. Infect. Dis. 195:1007-1013.
23. Pealer, L. N., A. A. Marfin, L. R. Petersen, R. S. Lanciotti, P. L. Page, S. L. Stramer, M. G. Stobierski, K. Signs, B. Newman, H. Kapoor, J. L. Goodman, and M. E. Chamberland. 2003. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349:12361245.
24. Raengsakulrach, B., A. Nisalak, N. Maneekarn, P. T. Yenchitsomanus, C. Limsomwong, A. Jairungsri, V. Thirawuth, S. Green, S. Kalayanarooj, S. Suntayakorn, N. Sittisombut, P. Malasit, and D. Vaughn. 2002. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. J. Virol. Methods 105:219232.
25. Ramos, M. M., H. Mohammed, E. Zielinski-Gutierrez, M. H. Hayden, J. L. Lopez, M. Fournier, A. R. Trujillo, R. Burton, J. M. Brunkard, L. AnayaLopez, A. A. Banicki, P. K. Morales, B. Smith, J. L. Munoz-Jordan, and S. H. Waterman. 2008. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am. J. Trop. Med. Hyg. 78:364-369.
26. Reiter, P. 2001. Climate change and mosquito-borne disease. Environ. Health Perspect. 109 (Suppl. 1) :141-161.
27. Rigau-Perez, J. G., et al. 1999. Surveillance for an emerging disease: dengue hemorrhagic fever in Puerto Rico, 1988-1997. P. R. Health Sci. J. 18:337345.
28. Rigau-Perez, J. G., A. V. Vorndam, and G. G. Clark. 2001. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am. J. Trop. Med. Hyg. 64:67-74.
29. Rothman, A. L., and F. A. Ennis.1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1-6.
30. Sa-ngasang, A., S. Wibulwattanakij, S. Chanama, A. O-rapinpatipat, A. A-nuegoonpipat, S. Anantapreecha, P. Sawanpanyalert, and I. Kurane. 2003. Evaluation of RT-PCR as a tool for diagnosis of secondary dengue virus infection. Jpn. J. Infect. Dis. 56:205-209.
31. Siqueira, J. B., Jr., C. M. Martelli, G. E. Coelho, A. C. Simplicio, and D. L. Hatch. 2005. Dengue and dengue hemorrhagic fever, Brazil, 1981-2002. Emerg. Infect. Dis. 11:48-53.
32. Stramer, S. L. 2000. Nucleic acid testing for transfusion- transmissible agents. Curr. Opin. Hematol. 7:387-391.
33. Stramer, S. L. 2005. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 45:1242-1246.
34. Stramer, S. L., C. T. Fang, G. A. Foster, A. G. Wagner, J. P. Brodsky, and R. Y. Dodd. 2005. West Nile virus among blood donors in the United States, 2003 and 2004. N. Engl. J. Med. 353:451-459.
35. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
36. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, A. L. Rothman, F. A. Ennis, and A. Nisalak. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176: 322-330.
37. World Health Organization. 2004. Guidelines for the evaluation of dengue vaccines in populations exposed to natural infections. World Health Organization, Geneva, Switzerland.